Court Place Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,292
Closed -$229K 167
2020
Q1
$229K Hold
1,292
0.1% 139
2019
Q4
$247K Hold
1,292
0.09% 158
2019
Q3
$217K Sell
1,292
-10
-0.8% -$1.63K 0.08% 168
2019
Q2
$218K Buy
+1,302
New +$180K 0.09% 165
2018
Q4
Sell
-1,352
Closed -$258K 182
2018
Q3
$258K Hold
1,352
0.1% 149
2018
Q2
$225K Sell
1,352
-100
-7% -$16.1K 0.09% 158
2018
Q1
$244K Hold
1,452
0.1% 148
2017
Q4
$238K Sell
1,452
-40
-3% -$7.18K 0.1% 149
2017
Q3
$306K Sell
1,492
-70
-4% -$16.3K 0.14% 129
2017
Q2
$380K Hold
1,562
0.18% 112
2017
Q1
$373K Hold
1,562
0.18% 110
2016
Q4
$328K Buy
+1,562
New +$324K 0.17% 111

Other funds holding AGN

Court Place Advisors's AGN Position: Q2 2020 in Review

Court Place Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,292 shares — an estimated $229K sold.

Court Place Advisors first reported a position in AGN in Q4 2016 and held it in 12 quarters. The position peaked at $380K in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Court Place Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Court Place Advisors sold 1,292 Allergan plc shares in Q2 2020, an estimated $229K.
  • Court Place Advisors first reported a position in Allergan plc in Q4 2016 and held it in 12 quarters.
  • Court Place Advisors's Allergan plc position peaked at $380K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Court Place Advisors's 13F filing for Q2 2020, filed 5 Aug 2020.